Mucinex Patent Ruling Breathes Life Into Watson And Perrigo ANDAs
This article was originally published in The Tan Sheet
Watson Pharmaceuticals' success against Reckitt Benckiser's Mucinex patent infringement suit could clear a path for Mucinex equivalents to launch in the first half of 2011.
You may also be interested in...
Watson prevails in Mucinex patent ruling
Reckitt Benckiser reports net revenue up 15% in its latest earnings period on strong sales of OTC products and new business from the now fully integrated SSL International brands.
Allegra available OTC nationwide